The current COVID-19 pandemic is the most disruptive event in the past 50 years, with a global impact on health care and world economies. It is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a coronavirus that uses angiotensin-converting enzyme 2 (ACE2) as an entry point to the cells. ACE2 is a transmembrane carboxypeptidase and member of the renin-angiotensin system. This mini-review summarizes the main findings regarding ACE2 expression and function in endocrine tissues. We discuss rapidly evolving knowledge on the potential role of ACE2 and SARS coronaviruses in endocrinology and the development of diabetes mellitus, hypogonadism, and pituitary and thyroid diseases.
CITATION STYLE
Lazartigues, E., Qadir, M. M. F., & Mauvais-Jarvis, F. (2020, September 1). Endocrine Significance of SARS-CoV-2’s Reliance on ACE2. Endocrinology (United States). Endocrine Society. https://doi.org/10.1210/endocr/bqaa108
Mendeley helps you to discover research relevant for your work.